title: Re: clinical validity/utility, change in practice patterns, and economic implications of risk stratifiers to predict outcomes for early-stage breast cancer: a systematic review.
authors.forename: Pierre-Jean
authors.initials: PJ
authors.lastname: Lamy
authors.forename: Pierre-Marie
authors.initials: PM
authors.lastname: Martin
authors.forename: Gilles
authors.initials: G
authors.lastname: Romieu
authors.forename: William
authors.initials: W
authors.lastname: Jacot
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D005260:Female; D020869:Gene Expression Profiling; D017048:Health Care Costs; D006801:Humans; D010818:Practice Patterns, Physicians'
chemical_list: D014408:Biomarkers, Tumor